Other languages Bio-Rad Laboratories, Inc. Nyse

Equities

BIO.B

US0905721082

Real-time Estimate Cboe BZX Other stock markets 01:41:31 2024-05-03 pm EDT			5-day change	1st Jan Change
281.7 ^USD	+0.63%		0.00%	-12.71%

Apr. 29	RBC Capital Adjusts Price Target on Bio-Rad Laboratories to $420 From $474	MT
Apr. 26	Bio-Rad Laboratories, Inc. Announces Executive Vice President and President Changes, Life Science Group	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bio-Rad Laboratories, Inc. Announces Executive Vice President and President Changes, Life Science Group	Apr. 26
Oncocyte Corporation and Bio-Rad Laboratories, Inc. Partner on Global Launch of Transplant Assay	Apr. 11
Bio-Rad Laboratories, Inc. Announces Chief Operating Officer Andrew Last to Retire	Apr. 10
Biodesix Strikes New Research Deal With Memorial Sloan Kettering Cancer Center	Mar. 25
Bio-Rad Laboratories Appoints Roop Lakkaraju as CFO	Mar. 20
Bio-Rad Laboratories, Inc. Appoints Roop K. Lakkaraju as New Executive Vice President Effective April 15, 2024	Mar. 20
Bio-rad Laboratories Insider Sold Shares Worth $1,008,000, According to a Recent SEC Filing	Feb. 29
Bio Rad Labs rises after posting upbeat fourth-quarter profit	Feb. 15
Bio-Rad Laboratories Q4 Adjusted Earnings, Revenue Decline, Shares Rise After-Hours	Feb. 15
Bio-Rad Laboratories, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 15
Bio-Rad Laboratories, Inc. Appoints Norman Schwartz as Principal Financial Officer	Feb. 14
Bio-rad Laboratories Insider Sold Shares Worth $358,992, According to a Recent SEC Filing	Dec. 13
Bio-Rad Laboratories, Inc. Announces Resignation of Dara Grantham Wright as Executive Vice-President and President, Effective January 12, 2024	Dec. 07
Activist investor Ubben shutting down Inclusive Capital -WSJ	Nov. 29
Bio-rad Laboratories Insider Sold Shares Worth $195,874, According to a Recent SEC Filing	Nov. 28
Bio-Rad Labs cuts 2023 revenue growth forecast as biotechs cut spending	23-10-26
Bio-Rad Laboratories Q3 Non-GAAP Earnings, Sales Decline -- Shares Drop After Hours	23-10-26
Bio-Rad Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-26
Viavi Solutions Appoints New CFO	23-10-18
Bio-Rad Laboratories, Inc. Announces Resignation of Ilan Daskal, Executive Vice-President and Principal Financial Officer, Effective November 6, 2023	23-10-17

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Bio-Rad Laboratories, Inc. Nyse

Equities

BIO.B

US0905721082

Other languages

Filters